HomeNewsBusinessUK will donate 10 million vaccines to Asian, commonwealth nations - but not to India

UK will donate 10 million vaccines to Asian, commonwealth nations - but not to India

The doses being donated are the University of Oxford and AstraZeneca collaboration vaccine, made by Oxford Biomedica in Oxford and packaged in Wrexham, north Wales.

July 30, 2021 / 08:48 IST
Story continues below Advertisement
This marks the first tranche of the 100 million vaccines Prime Minister Boris Johnson pledged the UK would share within the next year at last month's G-7 Summit in Cornwall, with 30 million due to be sent by the end of the year.
This marks the first tranche of the 100 million vaccines Prime Minister Boris Johnson pledged the UK would share within the next year at last month's G-7 Summit in Cornwall, with 30 million due to be sent by the end of the year.

India is excluded from the list of beneficiaries announced by the UK government for 10 million vaccine donations to Asian and commonwealth nations.

“We've just seen the announcement by UK government about donation of 10 million vaccines to the commonwealth and Asian countries. That announcement doesn't cover India as far as I'm aware. But we're ascertaining more details. We'll certainly share updates as soon we have it," said the Ministry of External Affairs spokesperson Arindam Bagchi in a press briefing on Thursday, as per ANI report.

Story continues below Advertisement

The UK will this week begin delivering COVID-19 vaccines around the world for lower-income countries to help tackle the pandemic, Foreign Secretary Dominic Raab had announced on Wednesday.

Five million doses are being offered to COVAX, the worldwide scheme to ensure equitable access to COVID-19 vaccines, which will be urgently distributed through an allocation system which prioritises delivering vaccines to countries who most need them. Another 4 million doses will be shared directly, with Indonesia to receive 600,000 doses, Jamaica 300,000 and 817,000 for Kenya among the list of countries.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show